SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) announced today that it will release its first quarter 2022 financial results on Thursday, May 5, 2022, after the close on the U.S -financial markets will publish. The Company will host a conference call and webcast at 4:30 pm ET to discuss financial results and provide general business updates.
Information about the conference call
| Date: | Thursday, May 5, 2022 |
| Time: | 4:30 p.m. ET |
| Dial-in numbers: | +1 (800) 289-0720 (US) or +1 (313) 209-5140 (International) |
| Verification code: | 7273768 |
| Live Webcast: | Travere.com in the Events & Presentations section of the Investors page. |
A replay of the call is available from May 5, 2022 7:30 PM ET to May 12, 2022 7:30 PM ET. The retry number is +1 (888) 203-1112 (US) or +1 (719) 457-0820 (International), confirmation code 7273768.
About Travere Therapeutics
At Travere Therapeutics, we are in rare cases for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers from all backgrounds navigate life with a rare disease. Along the way, we know that treatment options are urgently needed – that’s why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuing this mission, we continually strive to understand the diverse perspectives of rare patients and boldly break new ground to transform their lives and bring hope—today and tomorrow. Visit www.travere.com for more information
Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
[email protected]
Comments are closed.